New Two-Drug attack on tough head and neck cancers enters Late-Stage testing
NCT ID NCT06295731
Summary
This study is testing if adding a new drug called INBRX-106 to a standard immunotherapy (pembrolizumab) works better than the standard drug alone for people with advanced head and neck cancer that has spread or returned. It will involve about 410 patients whose cancer expresses a specific marker (PD-L1). The main goals are to see if the combination helps patients live longer without their cancer getting worse and if it causes more tumors to shrink.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA HNSCC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ARENSIA Clinic Oncology Institute Bucharest
Bucharest, 022328, Romania
-
Addenbrooke's Hospital
Cambridge, CB2 0QQ, United Kingdom
-
Antwerp University Hospital
Edegem, Antwerp, 2650, Belgium
-
Arensia Exploratory Medicine S.R.L in collaboration with "Prof. Dr. Ion Chiricuta" Oncology Institute
Cluj-Napoca, Cluj, 400015, Romania
-
Beacon Hospital
Petaling Jaya, 46050, Malaysia
-
CH Annecy Genevois
Annecy, Epagny Metz Tessy, 74370, France
-
CHRISTUS Spohn Cancer Center
Corpus Christi, Texas, 78404, United States
-
Cenre Oscar Lambret
Lille, 59000, France
-
Centre Jean Perrin
Clermont-Ferrand, 63011, France
-
Centre Leon Berard
Lyon, 69008, France
-
Changhua Christian Medical Foundation Changhua Christian Hospital
Changhua, 500, Taiwan
-
ChristianaCare Health Services
Newark, Delaware, 19713, United States
-
Christus St. Vincent Regional Cancer Center
Santa Fe, New Mexico, 87505, United States
-
Chu Ucl Namur Site De Sainte-Elisabeth
Namur, 5000, Belgium
-
City of Hope Medical Center
Duarte, California, 91010, United States
-
Cleveland Clinic Florida, The Maroone Cancer Center
Weston, Florida, 33331, United States
-
Complex Oncological Center Plovdiv EOOD Dept of Med Oncology and Oncological Diseases in Hematology
Plovdiv, 4004, Bulgaria
-
Complexo Hospitalario Universitario A Coruña
A Coruña, 15006, Spain
-
Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, 89169, United States
-
European Institute of Oncology
Milan, 20141, Italy
-
Fondazione IRCCS Policlinico San Matteo
Pavia, 27100, Italy
-
Gachon University Gil Medical Center of Korea
Seoul, Incheon, 21565, South Korea
-
Hospital Canselor Tuanku Muhriz (HCTM) UKM
Cheras, Kuala Lumpur, 56000, Malaysia
-
Hospital Clinic de Barcelona
Barcelona, 08036, Spain
-
Hospital Clinico Universitario de Santiago de Compostela
Santiago, A Coruña, 15706, Spain
-
Hospital Universitario Gregorio Marañón
Madrid, Retiro, 28007, Spain
-
Hospital Universitario de Navarra
Pamplona, Navarre, 31008, Spain
-
Hospital Universitario y Politécnico La Fe
Valencia, Spain
-
Hospital Universiti Sains Malaysia
Kubang Kerian, Kelantan, 16150, Malaysia
-
IOB / Institute of Oncology, Hospital Quirónsalud Barcelona
Barcelona, Gracia, 08023, Spain
-
Institut Kanser Negara
Putrajaya, 62250, Malaysia
-
Intermountain Health, St. Vincent Regional Hospital, Cancer Centers of Montana
Billings, Montana, 59102, United States
-
Intituto Catalán de Oncología
Barcelona, Catalonia, 08908, Spain
-
Istituto Nazionale Tumori IRCCS - (National Cancer Institute)
Milan, 20133, Italy
-
Istituto Nazionale Tumori IRCCS - Fondazione Giovanni Pascale (National Cancer Institute)
Naples, Naples, 80131, Italy
-
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, 80756, Taiwan
-
Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Keimyung University Dongsan Hospital of Korea
Daegu, 42601, South Korea
-
Korea Cancer Center Hospital
Seoul, 01812, South Korea
-
Korea University Anam Hospital
Seoul, 02841, South Korea
-
Korea University Guro Hospital
Seoul, 08308, South Korea
-
Los Angeles Cancer Network (LACN)
Los Angeles, California, 91204, United States
-
MD Anderson Cancer Centre
Madrid, 28033, Spain
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Medical Oncology Associates of San Diego
San Diego, California, 92123, United States
-
Mid Florida Hematology and Oncology Center
Orange City, Florida, 32763, United States
-
Mount Vernon Cancer Centre
Northwood, Middlesex, HA6 2RN, United Kingdom
-
Multiprofile Hospital for Active Treatment - "Uni Hospital" Ltd, Medical Oncology Dept
Panagyurishte, 4500, Bulgaria
-
Multiprofile Hospital for Active Treatment Sveta Sofia, Department of Medical Oncology
Sofia, 1618, Bulgaria
-
NHS Grampian / Aberdeen Royal Infirmary
Aberdeen, AB25 2ZN, United Kingdom
-
Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy Oddział w Gliwicach
Gliwice, 44-102, Poland
-
National Cheng Kung University Hospital
Tainan, 704, Taiwan
-
National Taiwan University Hospital
Taipei, 100226, Taiwan
-
Norton Cancer Institute
Louisville, Kentucky, 40202, United States
-
Norwich and Norfolk University Hospital
Norwich, NR47UY, United Kingdom
-
Oklahoma University Stephenson Cancer Center
Oklahoma City, Oklahoma, 73104, United States
-
Oncology Hematology West, PC dba Nebraska Cancer Specialists
Omaha, Nebraska, 68130, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
Provita Profamilia
Piotrkow Trybunalski, 97-300, Poland
-
Przychodnia Lekarska KOMED
Konin, 62-500, Poland
-
Pusan National University Yangsan Hospital
Yangsan, Gyeongsangnam-do, 50612, South Korea
-
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
-
Sarawak General Hospital
Kuching, Sarawak, 93586, Malaysia
-
Sarcoma Oncology Center
Santa Monica, California, 90403, United States
-
Sc Centrul de Oncologie Sf Nectarie Srl
Craiova, Dolj, 200745, Romania
-
Sc Oncolab Srl
Craiova, Dolj, 200385, Romania
-
Severance Hospital, Yonsei University Health System
Seoul, 03722, South Korea
-
Taichung Veterans General Hospital
Taichung, China, 407219, Taiwan
-
Taipei Veterans General Hospital
Taipei, Beitou District / R.o.c., 11217, Taiwan
-
The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Seoul, Eunpyeong-gu, 03312, South Korea
-
The Christie NHS Foundation Trust
Manchester, M204BX, United Kingdom
-
The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Northern Centre for Cancer Care, Freeman Hospital
Newcastle upon Tyne, Northumbria, NE7 7DN, United Kingdom
-
The Oncology Institute of Hope & Innovation
Miami, Florida, 33169, United States
-
The Royal Marsden NHS Foundation Trust, Chelsea
Chelsea, London, SW36JJ, United Kingdom
-
The Royal Marsden NHS Foundation Trust, Sutton
Sutton, Surrey, SM25PT, United Kingdom
-
Thomson Hospital Kota Damansara
Petaling Jaya, Selangor, 47810, Malaysia
-
UC Davis
Sacramento, California, 95817, United States
-
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, 27599-7305, United States
-
UNEOS-Hopital R.SCHUMAN
Metz, Moselle, 57000, France
-
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
-
Uni Multiprofile Hospital for Active Treatment Tsaritsa Yoanna - ISUL EAD Clinic of Medical Oncology
Sofia, 1527, Bulgaria
-
University Hospital Brussels
Jette, 1090, Belgium
-
University of Florida UF Health Cancer Center
Gainesville, Florida, 32608, United States
-
University of Illinois Cancer Center
Chicago, Illinois, 60612, United States
-
VCU Massey Comprehensive Cancer Center
Richmond, Virginia, 23298, United States
-
Vitaz
Sint-Niklaas, 9100, Belgium
-
Washington University St. Louis
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.